Sanofi signs letter of intent with Tricog Health
Sanofi will provide mentorship, market access support, and potential financial investment to Tricog, a health-tech startup that supplies virtual cardiac diagnostic tools and services that are built by combining artificial intelligence and medical expertise
Sanofi Healthcare India has signed a Letter of Intent (LOI) with Tricog Health, a Bharat Innovates startup. Under this partnership, .Sanofi will provide mentorship, market access support, and potential financial investment to Tricog, a health-tech startup that supplies virtual cardiac diagnostic tools and services that are built by combining artificial intelligence and medical expertise
The LOI was signed in the presence of Sebastien Coisne, Finance Business Partner International Pharma – General Medicines, Sanofi and senior officials from IIT Kanpur.
Sanofi came in touch with Tricog Health at the Bharat Innovates 2026 summit where the Ministry of Education, Government of India showcased 120 of India’s best deep tech startups at a global stage in France.
This partnership comes against the backdrop of the India-France Year of Innovation 2026, a bilateral initiative placing innovation at the core of the India-France relationship.
Deepak Arora, MD, Sanofi (India), said, “At Sanofi, we believe that the most transformative breakthroughs happen at the intersection of science, enterprise, and public purpose. This partnership with Tricog Health is a testament to our conviction in public-private collaboration as a driving force for change. We are proud to bring Sanofi’s global expertise to India’s brightest innovators and help them scale ideas that are pushing the boundaries of health-tech.
The Make in India story in healthcare is shifting from ambition to execution, with AI serving as the accelerator for innovation that can serve our own population and the world; and Sanofi is proud to be part of that journey; and Sanofi is proud to be part of that journey. As the nation continues to strengthen its position on the global innovation map, we are excited by the possibilities that lie ahead — because when science dvances, lives improve.”
Prateek Golecha, Chief Growth Officer, Tricog Health, said, “Partnering with Sanofi is an important milestone for Tricog and a strong validation of our shared belief that innovation must ultimately translate into better patient outcomes. Sanofi’s global healthcare experience, scientific ecosystem and market reach, combined with Tricog’s AI-powered cardiac diagnostic capabilities, can help us take life-saving cardiac care to many more patients, in India and beyond. In cardiovascular disease, timely detection can make the difference between life and death. Through this partnership, our ambition is simple: scale innovation faster, detect diseases earlier, and help save more lives.”
Sanofi also plans to engage with other healthcare innovators among the deep-tech ventures identified under the Bharat Innovates initiative, including those emerging from IITs and other higher education institutions, incubators, and innovation hubs across the country.
Sanofi will be extending its support to more start-ups like Tricog, such as Ahammune Biosciences, which focuses on innovation-led drug discovery targeting the skin immune system, and the Translational Health Science and Technology Institute, an institute of biotechnology research and innovation council.